Skip to main content

Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract

We determined the prescription rates of medications for the secondary prevention of ischaemic heart disease and left ventricular systolic dysfunction in stable dialysis patients. In patients with established ischaemic heart disease, statins, beta-blockers and renin–angiotensin–aldosterone system blockers were substantially underprescribed. Furthermore, beta-blockers and renin–angiotensin–aldosterone system blockers were prescribed in less than half of those with left ventricular systolic dysfunction. Contraindications to treatment were infrequent and did not explain these findings.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: dialysis; ischaemic heart disease; left ventricular systolic dysfunction; secondary prevention

Document Type: Research Article

Affiliations: 1: Departments of Cardiology 2: Nephrology, Wellington Hospital, Wellington, New Zealand

Publication date: 2008-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more